Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
BN.1.5.2NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
BN.1.5.2NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
BQ.1.31NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
BQ.1.31NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
BQ.1.31NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
BQ.1.1.41NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
BQ.1.1.41NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
BQ.1.1.41NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
BQ.1.1.46NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
BQ.1.1.46NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
BQ.1.1.46NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
CP.8NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
CP.8NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
CP.8NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
XBB.1.25NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
XBB.1.25NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
XBB.1.25NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
BQ.1.1.23NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
BQ.1.1.23NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
BQ.1.1.23NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
BA.5.2.18NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
BA.5.2.18NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
BA.5.2.18NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
BQ.1.11NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
BQ.1.11NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
BQ.1.11NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
BQ.1.1.3NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
BQ.1.1.3NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
BQ.1.1.3NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
EG.4.1NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
EG.4.1NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
EG.4.1NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
BQ.1.1.17NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
BQ.1.1.17NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
BQ.1.1.17NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
BE.1.1NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
BE.1.1NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
BE.1.1NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
BA.5.3.1NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
BA.5.3.1NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
BA.5.3.1NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
CR.1.1NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
CR.1.1NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
CR.1.1NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
BQ.1.2.3NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
BQ.1.2.3NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
BQ.1.2.3NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
BF.7.13NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
BF.7.13NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
BF.7.13NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used